Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 23 Jun 2017
At a glance
- Drugs Semaglutide (Primary) ; Dulaglutide
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms PIONEER 10
- Sponsors Novo Nordisk
- 20 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Jan 2017 Status changed from not yet recruiting to recruiting.
- 11 Jan 2017 New trial record